The U.S. clinical trials supply and logistics market size was estimated at USD 1.50 Billion in 2025 and is projected to reach USD 2.87 billion by 2033, growing at a CAGR of 8.45% from 2025 to 2033. The market has experienced robust growth driven by research and development activities for innovative therapeutic areas such as oncology, rare diseases, and cell and gene therapies.
Besides, the growing complexity of trial designs and regulatory requirements for patient safety and product integrity has led to the need for advanced supply chain models. Further, the adoption of decentralized trials and direct-to-patient delivery solutions has highlighted the significance of flexible and compliant logistics networks. In addition, increased investment from pharmaceutical and biotech companies has enhanced the demand for efficient packaging, temperature-controlled storage, and distribution services essential for timely trial execution.
Moreover, most clinical trials across various phases have been supported by specialized supply solutions such as cold chain distribution, comparator sourcing, clinical packaging, and return management. Smaller batch distributions with tight timelines have been effectively managed for early-phase studies through adaptable supply models, while large-scale Phase III trials benefit from comprehensive global depot networks. Besides, the expanding pipeline of biologics, biosimilars, and advanced therapies has further boosted the need for ultra-low temperature handling and specialized transportation solutions. As trials broaden in scope and geographical reach, supply and logistics providers have become crucial in ensuring the continuous availability of investigational products. Their role has been vital in fueling market expansion by minimizing delays, ensuring compliance, and enhancing trial efficiency.
Furthermore, established market players are pursuing strategic initiatives, including acquisitions, service expansions, and investments in digital platforms to enhance visibility and tracking. Collaborations with sponsors and contract research organizations (CROs) are being accelerated, focusing on increasing cold chain capacity in the U.S. to address the challenges posed by growing trial complexity. Such factors are expected to drive the market over the estimated timeframe.
This product will be delivered within 2 business days.
Besides, the growing complexity of trial designs and regulatory requirements for patient safety and product integrity has led to the need for advanced supply chain models. Further, the adoption of decentralized trials and direct-to-patient delivery solutions has highlighted the significance of flexible and compliant logistics networks. In addition, increased investment from pharmaceutical and biotech companies has enhanced the demand for efficient packaging, temperature-controlled storage, and distribution services essential for timely trial execution.
Moreover, most clinical trials across various phases have been supported by specialized supply solutions such as cold chain distribution, comparator sourcing, clinical packaging, and return management. Smaller batch distributions with tight timelines have been effectively managed for early-phase studies through adaptable supply models, while large-scale Phase III trials benefit from comprehensive global depot networks. Besides, the expanding pipeline of biologics, biosimilars, and advanced therapies has further boosted the need for ultra-low temperature handling and specialized transportation solutions. As trials broaden in scope and geographical reach, supply and logistics providers have become crucial in ensuring the continuous availability of investigational products. Their role has been vital in fueling market expansion by minimizing delays, ensuring compliance, and enhancing trial efficiency.
Furthermore, established market players are pursuing strategic initiatives, including acquisitions, service expansions, and investments in digital platforms to enhance visibility and tracking. Collaborations with sponsors and contract research organizations (CROs) are being accelerated, focusing on increasing cold chain capacity in the U.S. to address the challenges posed by growing trial complexity. Such factors are expected to drive the market over the estimated timeframe.
U.S. Clinical Trials Supply And Logistics Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. clinical trials supply & logistics market report based on service, phase, therapeutic area, and end-use.Service Outlook (Revenue, USD Million, 2021-2033)
- Logistics & Distribution
- Storage & Retention
- Packaging, Labeling, and Blinding
- Manufacturing
- Comparator Sourcing
- Other Services
Phase Outlook (Revenue, USD Million, 2021-2033)
- Phase I
- Phase II
- Phase III
- Phase IV
Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- Cardiovascular Diseases
- Respiratory Diseases
- CNS And Mental Disorders
- Others
End-use Outlook (Revenue, USD Million, 2021-2033)
- Pharmaceuticals
- Biologicals
- Medical Device
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Research Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Clinical Trials Supply & Logistics Market Variables, Trends & Scope
Chapter 4. U.S. Clinical Trials Supply & Logistics Market: Service Estimates & Trend Analysis
Chapter 5. U.S. Clinical Trials Supply & Logistics Market: Phase Estimates & Trend Analysis
Chapter 6. U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area Estimates & Trend Analysis
Chapter 7. U.S. Clinical Trials Supply & Logistics Market: End Use Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this U.S. Clinical Trials Supply and Logistics market report include:- hermo Fisher Scientific Inc.
- PS Healthcare
- iramal Pharma Solutions
- HL
- arexel International
- lmac Group
- DG Healthcare
- edEx
- atalent, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | September 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 1.5 Billion |
| Forecasted Market Value ( USD | $ 2.87 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | United States |
| No. of Companies Mentioned | 9 |
